Didn’t Expect That to Happen: Events That Must be Reported Promptly to the IRB
Learn what events need to be reported to the IRB after study approval and explore scenarios to help evaluate potentially reportable events.
Learn what events need to be reported to the IRB after study approval and explore scenarios to help evaluate potentially reportable events.
Gene therapy studies are a relatively recent addition to the world of clinical research. As a result, the unique requirements
As many research organizations are becoming more patient-centric and adapting to technological advancements and remote requirements, they are re-designing the
About the Advarra In Conversations With… The future of healthcare innovation hinges on research and clinical trials. Advarra sits down
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
The year 2021 brought many advancements in the clinical research industry. We’ve pushed for more diversity and inclusion in clinical
Historically, decentralized clinical trials (DCTs) were heralded as the future of patient-centered research. But how can your organization “walk the
Phase I oncology trials present distinct ethical challenges, such as participant vulnerability and the risk of therapeutic misconception, requiring careful oversight.
Transcript Institutions, universities, academic medical centers, hospitals, and healthcare systems all play a critical role in clinical research. In the
As the COVID-19 pandemic has forced a shift toward remote modalities, mobile health (mHealth) technologies have been on the rise.
Gene therapy research is highly regulated due to associated risks, often leading to confusion among professionals new to its regulatory requirements.
When SARS-CoV-2 (the virus causing the disease COVID-19) broke out in 2020, the clinical research community needed to pivot quickly